)
Company research29 Apr 2026
Target Corporation: The Business Behind the Bullseye
How Target grew from a Minneapolis dry goods store into a retail giant, blending discount pricing with design and private-label power.
Kalaris Therapeutics
Kalaris Therapeutics (KLRS) investor relations material
Kalaris Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary24 Apr, 2026
Executive summary
Annual meeting scheduled for June 3, 2026, to be held exclusively online for stockholders of record as of April 6, 2026.
Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report on Form 10-K, are available online, with paper or email copies available upon request by May 22, 2026.
Voting matters and shareholder proposals
Election of three Class III directors to serve three-year terms expiring at the 2029 annual meeting.
Advisory vote on executive compensation (say-on-pay) included.
Advisory vote on the frequency of future executive compensation advisory votes.
Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Board recommends voting for all director nominees, for the executive compensation proposal, one year for the frequency of say-on-pay, and for auditor ratification.
Board of directors and corporate governance
Director nominees are Napoleone Ferrara, M.D., David Hallal, and Leone Patterson.
Each nominee, if elected, will serve until the 2029 annual meeting and until a successor is duly elected and qualified.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Kalaris Therapeutics
- Board recommends approval of all proposals; Samsara LP retains majority control.KLRS
Proxy filing24 Apr 2026 - Up to $350M in securities registered, including $100M ATM equity, to fund R&D and operations.KLRSRegistration filing3 Apr 2026
- Registering 5M shares for resale post-$50M private placement; focus on novel retinal therapy.KLRSRegistration filing3 Apr 2026
- TH103 shows rapid efficacy, strong durability, and safety in early trials, supporting further development.KLRSCorporate presentation20 Mar 2026
- Strong clinical progress and $118M cash position support operations through 2027.KLRSQ4 202517 Mar 2026
- Merger forms a leading retinal disease biotech with $100M cash and a novel anti-VEGF therapy.KLRSM&A Announcement15 Jan 2026
- Reverse stock split and adjournment proposals were voted on, with results to be published post-meeting.KLRSEGM 202510 Jan 2026
- 2025 meeting to elect directors, ratify auditor, and review governance under majority control.KLRSProxy Filing2 Dec 2025
- Shareholders will vote on a reverse stock split to maintain Nasdaq listing and enable a merger.KLRSProxy Filing2 Dec 2025
Next Kalaris Therapeutics earnings date
Q1 202613 May, 2026
Kalaris Therapeutics
Next Kalaris Therapeutics earnings date
Q1 202613 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Business philosophy23 Apr 2026
Greg Foran: The New CEO of Kroger
How Greg Foran rose from store floor to CEO of Kroger, led Walmart's turnaround, and built a leadership style focused on execution.
)
Company research22 Apr 2026
Companies That Had Their IPO in 2025: The IPO Market Recovers
After years of uncertainty, 2025 marked the IPO market's return, with major listings like Klarna and Figma signaling renewed momentum.
Frequently asked questions
Explore our global coverage